Your browser doesn't support javascript.
loading
Genetic link between KIF1A mutations and amyotrophic lateral sclerosis: evidence from whole-exome sequencing.
Zheng, Wei; He, Ji; Chen, Lu; Yu, Weiyi; Zhang, Nan; Liu, Xiaoxuan; Fan, Dongsheng.
Afiliación
  • Zheng W; Department of Neurology, Peking University Third Hospital, Beijing, China.
  • He J; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.
  • Chen L; Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.
  • Yu W; Department of Neurology, Peking University Third Hospital, Beijing, China.
  • Zhang N; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.
  • Liu X; Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.
  • Fan D; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China.
Front Aging Neurosci ; 16: 1421841, 2024.
Article en En | MEDLINE | ID: mdl-39076207
ABSTRACT

Objectives:

Genetics have been shown to have a substantial impact on amyotrophic lateral sclerosis (ALS). The ALS process involves defects in axonal transport and cytoskeletal dynamics. It has been identified that KIF1A, responsible for encoding a kinesin-3 motor protein that carries synaptic vesicles, is considered a genetic predisposing factor for ALS.

Methods:

The analysis of whole-exome sequencing data from 1,068 patients was conducted to examine the genetic link between ALS and KIF1A. For patients with KIF1A gene mutations and a family history, we extended the analysis to their families and reanalyzed them using Sanger sequencing for cosegregation analysis.

Results:

In our cohort, the KIF1A mutation frequency was 1.31% (14/1,068). Thirteen nonsynonymous variants were detected in 14 ALS patients. Consistent with the connection between KIF1A and ALS, the missense mutation p.A1083T (c.3247G>A) was shown to cosegregate with disease. The mutations related to ALS in our study were primarily located in the cargo-binding region at the C-terminal, as opposed to the mutations of motor domain at the N-terminal of KIF1A which were linked to hereditary peripheral neuropathy and spastic paraplegia. We observed high clinical heterogeneity in ALS patients with missense mutations in the KIF1A gene. KIF5A is a more frequent determinant of ALS in the European population, while KIF1A accounts for a similar proportion of ALS in both the European and Chinese populations.

Conclusion:

Our investigation revealed that mutations in the C-terminus of KIF1A could increase the risk of ALS, support the pathogenic role of KIF1A in ALS and expand the phenotypic and genetic spectrum of KIF1A-related ALS.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Aging Neurosci Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Aging Neurosci Año: 2024 Tipo del documento: Article